Company Profile
Arvinas, Inc. Stock Price, News & Analysis
- Ticker:
- ARVN
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Why the stock is moving
Current closing-price context is not available for ARVN.
Company overview
Business overview
Arvinas is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Arvinas is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Arvinas follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Arvinas sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
The next few months for Arvinas are centered on its latest development priorities. The latest company update points to First-ever FDA approved PROTAC supports the further development and potential of Arvinas’ pipeline. If that progress holds, the program should stay on the radar through the rest of the quarter.
Recent news
- 01
- 02
Arvinas to Present at Jefferies Global Healthcare Conference
Source: Arvinas, Inc.
- 03
Arvinas Employees Give Back During Company-wide Impact Day
Source: Arvinas, Inc.
- 04
Arvinas Reports First Quarter 2026 Financial Results and Provides Corporate Update
Source: Arvinas, Inc.
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Arvinas, Inc. (ARVN)?
Arvinas, Inc. (ARVN) most recently closed at 10.78 USD, a +2.57% move versus the previous session.
What is the market cap of Arvinas, Inc. (ARVN)?
Arvinas, Inc. currently has a market capitalization of 695M USD on BioPharmSignal.
What does Arvinas, Inc. do?
Arvinas is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is ARVN stock listed?
Arvinas, Inc. (ARVN) is associated with NASDAQ, United States, Biopharma.
What is Arvinas?
The next few months for Arvinas are centered on its latest development priorities.
Which conditions is Arvinas, Inc. targeting with Arvinas?
The next few months for Arvinas are centered on its latest development priorities.
How does Arvinas, Inc. describe recent progress with Arvinas?
The next few months for Arvinas are centered on its latest development priorities.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.